Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 3, 2009, Pages 1319-1328

  Warboys, Christina M ^a,b   Toh, Hong Boon ^a,c   Fraser, Paul A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; APOCYNIN; BOVINE SERUM ALBUMIN; BRADYKININ; CALPHOSTIN C; CATALASE; IMMUNOGLOBULIN G; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SULFORHODAMINE B; SUPEROXIDE DISMUTASE; ACETOPHENONE DERIVATIVE; ADVANCED GLYCATION END PRODUCTS BOVINE SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS-BOVINE SERUM ALBUMIN; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CALCIUM; FLUORESCENT DYE; IMMUNOGLOBULIN RECEPTOR; LISSAMINE RHODAMINE B; PROTEIN KINASE C; RHODAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA CELL; RETINAL MICROVASCULAR PERMEABILITY; ANIMAL; CAPILLARY PERMEABILITY; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; RETINA BLOOD VESSEL; VASCULAR ENDOTHELIUM; WISTAR RAT;

ACETOPHENONES; ANIMALS; BRADYKININ; CALCIUM; CAPILLARY PERMEABILITY; CATALASE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; NADPH OXIDASE; PROTEIN KINASE C; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; RETINAL VESSELS; RHODAMINES; SERUM ALBUMIN, BOVINE; SUPEROXIDE DISMUTASE;

EID: 62649094525     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2730     Document Type: Article

References (40)

1. Cunha-Vaz JG, Bernardes R. Nonproliferative retinopathy in diabetes type 2: initial stages and characterisation of phenotypes. Prog Retin Eye Res. 2005;24:355-377.
2. Waltman SR, Oestrich C, Krupin T, Hanish S. Quantitative vitreous fluorophotometry: a sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients. Diabetes. 1978;27:85-87.
3. Cunha-Vaz JG, Faria de Abreu JR, Campos AJ. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol. 1975;59: 649-656.
4. Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969;40:648-677.
5. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129-146.
6. Hammes HP, Alt A, Niwa T, et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia. 1999;42:728-736.
7. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. Advanced glycation end products (AGEs) co-localise with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol. 1997;150:523-531.
8. Boehm BO, Schilling S, Rosinger S, et al. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia. 2004;47:1376-1379.
9. Genuth S, Sun W, Cleary P, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes. 2005;54:3103-3111.
10. Stitt AW, Bhaduri T, McMullen CB, Gardiner TA, Archer DB. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. Mol Cell Biol Res Comm. 2000; 3:380-388.
11. Leto G, Pricci F, Amadio L, Iacobini C. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation. Diabetes Metab Res Rev. 2001;17:448-458.
12. Sampietro T, Bertuglia S, Colantuoni A, Bionda A, Lenzi S, Donato L. Increased permeability of hamster microcirculation to glycosylated albumin. Lancet. 1987;2:994-996.
13. Kislinger T, Fu C, Huber B, et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1999;274:31740-31749.
14. Bonnardel-Phu E, Wautier JL, Schmidt AM, Avila C, Vicaut E. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes. 1999;48:2052-2058.
15. Wautier JL, Zoukourian C, Chappey O, et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest. 1996;97:238-243.
16. Xu B, Chibber R, Ruggiero D, et al. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J. 2003;17:1289-1291.
17. Easton AS, Sarker MH, Fraser PA. Two components of blood-brain barrier disruption in the rat. J Physiol. 1997;503(pt 3):613-623.
18. Fraser PA, Dallas AD. Measurement of filtration coefficient in single cerebral microvessels of the frog. J Physiol. 1990;423:343-361.
19. Sarker MH, Easton AS, Fraser PA. Regulation of cerebral microvascular permeability by histamine in the anaesthetized rat. J Physiol. 1998;507(pt 3):909-918.
20. Schmidt AM, Hasu M, Popov D, et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci U S A. 1994;91:8807-8811.
21. Rota R, Chiavaroli C, Garay RP, Hannaert P. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur J Pharmacol. 2004;495:217-224.
22. Whiteman M, Ketsawatsakul U, Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann N Y Acad Sci. 2002;962:242-259.
23. Hawkins BJ, Madesh M, Kirkpatrick CJ, Fisher AB. Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. Mol Biol Cell. 2007;18:2002-2012.
24. Easton AS, Fraser PA. Arachidonic acid increases cerebral microvascular permeability by free radicals in single pial microvessels of the anaesthetized rat. J Physiol. 1998;507(pt 2):541-547.
25. Sarker MH, Hu DE, Fraser PA. Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat. J Physiol. 2000;528(pt 1:177-187.
26. Chiueh CC. Neuroprotective properties of nitric oxide. Ann N Y Acad Sci. 1999;890:301-311.
27. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000;87:26-32.
28. Al-Shabrawey M, Rojas M, Sanders T, et al. Role of NADPH oxidase in retinal vascular inflammation. Invest Ophthalmol Vis Sci. 2008; 49-3239-3244.
29. Kitada M, Koya D, Sugimoto T, et al. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes. 2003;52:2603-2614.
30. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AB. Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest. 1990;85:1991-1998.
31. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87: 245-313.
32. van Leeuwen FN, van Delft S, Kain HE, van der Kammen RA, Collard JG. Rac regulates phosphorylation of the myosin-II heavy chain, actinomyosin disassembly and cell spreading. Nat Cell Biol. 1999;1:242-248.
33. 2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechansims. Biochem Pharmacol. 2004;67:491-502.
34. 2+-ATPase activity of masseter muscle sarcoplasmic reticulum. Jpn J Pharmacol. 1995;67:21-28.
35. Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke. 2002;33:1706-1711.
36. Bogatcheva NV, Garcia JGN, Verin AD. Role of tyroisne kinase signalling in endothelial cell barrier regulation. Vascul Pharmacol. 2003;39:201-212.
37. Mamputu JC, Renier G. Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells: inhibitory effect of gliclazide. J Diabetes Complications. 2002;16:284-293.
38. Ozaki H, Yu AY, Della N, et al. Hypoxia inducible factor-alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci. 1999;40:182-189.
39. Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994;269: 9889-9897.
40. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007:2007;95103.